NOPAIN for Veterans Act

Summary

Requires the Department of Veterans Affairs to add FDA-approved or cleared non-opioid pain management drugs and biological products to the VA national formulary on a set schedule tied to FDA approval and certain Medicare payment eligibility rules. It defines “non-opioid pain management drug or biological product,” mandates implementation steps within 90 days of enactment, and prohibits using the Cost of War Toxic Exposures Fund to pay to carry out these changes.

• Adds a definition for FDA-approved/cleared non-opioid pain drugs and biological products for VA formulary purposes.
• Requires VA to include eligible non-opioid pain products in its national formulary on a set schedule tied to FDA approval or Medicare payment eligibility.
• Product inclusion deadline is the earlier of 1 year after Medicare payment eligibility or 18 months after FDA approval.
• Secretary of Veterans Affairs must implement the statutory changes within 90 days of enactment.
• Prohibits use of the Cost of War Toxic Exposures Fund to carry out these amendments.
• Covers only FDA-approved or FDA-cleared products that meet the new definition; non-FDA products remain excluded.
• Does not appropriate new funding or create a new entitlement; effects are implemented within existing VA processes and budgets.
• Requires VA administrative coordination with FDA and Medicare payment signals to meet inclusion timelines.